7777 Stock Overview
Develops self-assembling peptide technology in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
3-D Matrix, Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥116.00 |
| 52 Week High | JP¥179.00 |
| 52 Week Low | JP¥97.00 |
| Beta | 0.52 |
| 11 Month Change | 16.00% |
| 3 Month Change | -20.00% |
| 1 Year Change | -30.95% |
| 33 Year Change | -65.78% |
| 5 Year Change | -78.60% |
| Change since IPO | -64.44% |
Recent News & Updates
Recent updates
We Think 3-D Matrix (TSE:7777) Has A Fair Chunk Of Debt
Sep 10
3-D Matrix, Ltd. (TSE:7777) Doing What It Can To Lift Shares
Jun 08Investors Continue Waiting On Sidelines For 3-D Matrix, Ltd. (TSE:7777)
Feb 263-D Matrix (TYO:7777) Is Carrying A Fair Bit Of Debt
Apr 223-D Matrix's (TYO:7777) Shareholders Are Down 68% On Their Shares
Feb 23Shareholder Returns
| 7777 | JP Biotechs | JP Market | |
|---|---|---|---|
| 7D | 4.5% | 6.4% | 0.9% |
| 1Y | -31.0% | 20.4% | 11.9% |
Return vs Industry: 7777 underperformed the JP Biotechs industry which returned 20.4% over the past year.
Return vs Market: 7777 underperformed the JP Market which returned 11.9% over the past year.
Price Volatility
| 7777 volatility | |
|---|---|
| 7777 Average Weekly Movement | 6.8% |
| Biotechs Industry Average Movement | 8.4% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.6% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 7777's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 7777's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 106 | Jun Okada | www.3d-matrix.co.jp |
3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.
3-D Matrix, Ltd. Fundamentals Summary
| 7777 fundamental statistics | |
|---|---|
| Market cap | JP¥11.34b |
| Earnings (TTM) | -JP¥1.05b |
| Revenue (TTM) | JP¥5.25b |
2.2x
P/S Ratio-10.9x
P/E RatioIs 7777 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7777 income statement (TTM) | |
|---|---|
| Revenue | JP¥5.25b |
| Cost of Revenue | JP¥1.66b |
| Gross Profit | JP¥3.59b |
| Other Expenses | JP¥4.64b |
| Earnings | -JP¥1.05b |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
Dec 12, 2024
| Earnings per share (EPS) | -10.64 |
| Gross Margin | 68.36% |
| Net Profit Margin | -20.02% |
| Debt/Equity Ratio | 394.8% |
How did 7777 perform over the long term?
See historical performance and comparison